Clinical Trials Logo

Cataracts clinical trials

View clinical trials related to Cataracts.

Filter by:

NCT ID: NCT01936727 Completed - Cataracts Clinical Trials

Comparison of Two Phacoemulsification-methods: EasyTip 2.2mm vs. Infusion Assisted EasyTip 2.2mm

Start date: December 2011
Phase: N/A
Study type: Interventional

The aim of this study was to compare the intraoperative efficiency, safety and postoperative outcomes of cataract surgery with two different "high-fluidic" settings.

NCT ID: NCT01936714 Completed - Cataracts Clinical Trials

Comparison of Two Phacoemulsification-methods: Low Fluidic EasyTip 2.2mm vs. High Fluidic EasyTip 2.2mm

Start date: February 2013
Phase: N/A
Study type: Interventional

The aim of this study was to compare the intraoperative efficiency, safety and postoperative outcomes of cataract surgery with two different "high-fluidic" settings.

NCT ID: NCT01898728 Completed - Cataracts Clinical Trials

Comparison of the Effectiveness of Povidone-iodine in Reducing Conjunctival Bacterial Load Prior to Cataract Surgery in Patients Treated With a Lidocaine Gel Dilating Formulation Versus Eye Drops: A Randomized Controlled Trial

Start date: December 2012
Phase: N/A
Study type: Interventional

The eye contains a lens that focuses light. A clouding of the lens is known as a cataract. Cataracts decrease vision. The treatment for cataracts is cataract surgery. Cataract surgery is one of the most commonly performed surgical procedures. Although rare, complications of cataract surgery are significant given the number of people who have surgery each year and more serious complications may have a significant impact on the vision and quality of patients. Endophthalmitis is an infection in the eye and it is one of the worst complications of cataract surgery. Most of these infections are caused by bacteria from the patient's skin and conjunctiva, which makes cleaning the skin and eye before surgery very important. Before cataract surgery, patients receive an umber of eye drops; many surgical centers have a combination of medications in a thick gel, so that the medications remain in the eye for a long period of time, which may improve their effect. Laboratory studies suggest that the antibacterial effect of cleaning solutions may be inhibited by gels but this has not been proven, and many believe it to be untrue. This study is to compare the amount of bacteria on the eye prior to surgery in patients receiving a gel formulation of the medications before surgery as compared to those receiving the same medication in eye drop (liquid) form.

NCT ID: NCT01867541 Completed - Cataracts Clinical Trials

Intra-operative Measurements to Predict the Position of the Intraocular Lens Post-operatively

Start date: December 2010
Phase: N/A
Study type: Observational

Refractive outcome after cataract surgery mainly depends on the prediction of the intraocular lens that is implanted in the eye during surgery. Aim of this study is to measure the position of the lens capsule during surgery and to use this measurements to improve post-operative refractive outcomes.

NCT ID: NCT01846078 Completed - Cataracts Clinical Trials

Accuracy of Holladay 2 Formula in the Absence of Lens Thickness

Start date: June 2012
Phase: N/A
Study type: Interventional

Hypothesis: Holladay 2 formula is still accurate even used without lens thickness data.

NCT ID: NCT01684007 Completed - Cataracts Clinical Trials

A Clinical Outcome Study of Two Multifocal Intraocular Lenses (IOL) in Cataract Patients

Start date: November 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to compare AcrySof® IQ ReSTOR® +2.5 D Multifocal IOL in both eyes (bilateral implantation) to AcrySof® IQ ReSTOR® +2.5 D Multifocal IOL in the dominant eye with AcrySof® IQ ReSTOR® +3.0 D Multifocal IOL in the fellow eye (contralateral implantation) at Month 3 following the second eye surgery.

NCT ID: NCT01605877 Completed - Cataracts Clinical Trials

AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (IOL) Model SN6AD2 [SV25T0] in Japan

Start date: May 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate safety and effectiveness of AcrySof® IQ ReSTOR® +2.5 D Multifocal IOL Model SN6AD2 [SV25T0] in Japanese cataract patients.

NCT ID: NCT01601665 Completed - Astigmatism Clinical Trials

Post Approval Study of the AcrySof® IQ Toric Intraocular Lens (IOL) Models SN6AT6-SN6AT9

Start date: February 2012
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the use of toric high cylinder power intraocular lenses in a larger population in clinical practice and assure the continued safety of these approved devices.

NCT ID: NCT01515826 Withdrawn - Cataracts Clinical Trials

VIGADEXA Gel Compared to VIGADEXA Solution Following Cataract Surgery

Start date: March 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare VIGADEXA (moxifloxacin 0.5%/dexamethasone phosphate 0.075%) ophthalmic gel to VIGADEXA (moxifloxacin 0.5%/dexamethasone phosphate 0.1%) ophthalmic solution in the prevention of postoperative inflammation and infection.

NCT ID: NCT01510717 Completed - Cataracts Clinical Trials

Clinical Investigation of AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (IOL) Model SN6AD2 [SV25T0]

Start date: February 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the safety and efficacy of an investigational multifocal intraocular lens (IOL) to an FDA-approved monofocal IOL.